A phase II study of epratuzumab and rituximab in combination with cyclophsophamide, doxorubicin, vincrisine, and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma
- Citation:
- J Clin Oncol vol 86 (15s) abstr 8500
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 196
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- I. N. Micallef M. J. Maurer D. A. Nikcevich M. Cannon D. F. Moore Jr P. Kurtin T. E. Witzig
- Networks:
- Study
- NCCTG-N0489
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: